Semax
ACTH 4-7 PGP
- Peptide length
- 7 amino acids
Modified peptide fragment
Open the sources to check how the studies were done and what they can support.
An ACTH-derived peptide investigated in experimental ischemia and small human imaging studies.
- Family
- ACTH-derived analog
- Research target
- Experimental neurotrophic signaling
- Molecular form
- Modified peptide fragment
What to know about the research
Changes in gene expression or resting-state imaging are not equivalent to demonstrated cognitive benefit or stroke recovery.
Check the exact compound
Distinguish Semax from N-acetylated or amidated marketed variants; source evidence must match the exact molecule.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries